WO2005032234A3 - Agent reduisant les consequences nefastes de l'intoxication ethylique aigue - Google Patents

Agent reduisant les consequences nefastes de l'intoxication ethylique aigue Download PDF

Info

Publication number
WO2005032234A3
WO2005032234A3 PCT/RU2004/000517 RU2004000517W WO2005032234A3 WO 2005032234 A3 WO2005032234 A3 WO 2005032234A3 RU 2004000517 W RU2004000517 W RU 2004000517W WO 2005032234 A3 WO2005032234 A3 WO 2005032234A3
Authority
WO
WIPO (PCT)
Prior art keywords
ill effects
acute alcohol
alcohol intoxication
agent
intoxication
Prior art date
Application number
PCT/RU2004/000517
Other languages
English (en)
French (fr)
Other versions
WO2005032234A2 (fr
Inventor
Dmitry Nikolaevich Myasnikov
Alex Kashlinsky
Vladimir Pavlovich Nuzhny
Vladimir Vsevolodovi Rozhanets
Original Assignee
Dmitry Nikolaevich Myasnikov
Alex Kashlinsky
Vladimir Pavlovich Nuzhny
Vladimir Vsevolodovi Rozhanets
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dmitry Nikolaevich Myasnikov, Alex Kashlinsky, Vladimir Pavlovich Nuzhny, Vladimir Vsevolodovi Rozhanets filed Critical Dmitry Nikolaevich Myasnikov
Publication of WO2005032234A2 publication Critical patent/WO2005032234A2/ru
Publication of WO2005032234A3 publication Critical patent/WO2005032234A3/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Inorganic Chemistry (AREA)
  • Addiction (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
PCT/RU2004/000517 2004-02-26 2004-12-23 Agent reduisant les consequences nefastes de l'intoxication ethylique aigue WO2005032234A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2004105529 2004-02-26
RU2004105529/15A RU2250778C1 (ru) 2004-02-26 2004-02-26 Средство, снижающее неблагоприятные последствия острой алкогольной интоксикации

Publications (2)

Publication Number Publication Date
WO2005032234A2 WO2005032234A2 (fr) 2005-04-14
WO2005032234A3 true WO2005032234A3 (fr) 2005-07-28

Family

ID=34420877

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/RU2004/000517 WO2005032234A2 (fr) 2004-02-26 2004-12-23 Agent reduisant les consequences nefastes de l'intoxication ethylique aigue

Country Status (2)

Country Link
RU (1) RU2250778C1 (ru)
WO (1) WO2005032234A2 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2570126B1 (en) 2011-09-16 2014-03-26 Darius Rassoulian Use of melatonin for treating acute alcohol intoxication

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2043113C1 (ru) * 1995-02-06 1995-09-10 Андрей Борисович Рейзин Сбор лекарственных растений "алкомаг" для лечения алкогольной зависимости
RU2129008C1 (ru) * 1998-09-26 1999-04-20 Федеральное государственное учреждение Научно-исследовательский институт Традиционных методов лечения МЗРФ Сбор вытрезвляющий "трезлевтон"
US5968520A (en) * 1996-11-07 1999-10-19 Nam; Jong Hyun Natural teas for taking off the effects of drink and process for the production thereof
RU2160589C1 (ru) * 2000-05-18 2000-12-20 Алекс Кашлинский Средство для снижения алкогольного опьянения, предупреждения и снятия алкогольной интоксикации и похмельного синдрома и способ снижения алкогольного опьянения, предупреждения и снятия алкогольной интоксикации и похмельного синдрома с использованием этого средства
RU2167655C1 (ru) * 2000-07-03 2001-05-27 Научно-исследовательский институт психического здоровья Томского научного центра СО РАМН Средство для купирования алкогольного абстинентного синдрома

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2043113C1 (ru) * 1995-02-06 1995-09-10 Андрей Борисович Рейзин Сбор лекарственных растений "алкомаг" для лечения алкогольной зависимости
US5968520A (en) * 1996-11-07 1999-10-19 Nam; Jong Hyun Natural teas for taking off the effects of drink and process for the production thereof
RU2129008C1 (ru) * 1998-09-26 1999-04-20 Федеральное государственное учреждение Научно-исследовательский институт Традиционных методов лечения МЗРФ Сбор вытрезвляющий "трезлевтон"
RU2160589C1 (ru) * 2000-05-18 2000-12-20 Алекс Кашлинский Средство для снижения алкогольного опьянения, предупреждения и снятия алкогольной интоксикации и похмельного синдрома и способ снижения алкогольного опьянения, предупреждения и снятия алкогольной интоксикации и похмельного синдрома с использованием этого средства
RU2167655C1 (ru) * 2000-07-03 2001-05-27 Научно-исследовательский институт психического здоровья Томского научного центра СО РАМН Средство для купирования алкогольного абстинентного синдрома

Also Published As

Publication number Publication date
WO2005032234A2 (fr) 2005-04-14
RU2250778C1 (ru) 2005-04-27

Similar Documents

Publication Publication Date Title
AR054154A1 (es) Mezcla acida para bebida deportiva destinada a reducir o eliminar el regusto
WO2001068096A3 (en) Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders
MX2007012443A (es) Formulaciones farmaceuticas orales que comprenden acido fenofibrico y/o sus sales.
GT200400239A (es) Procedimiento para la preparacion de una composicion farmaceutica solida administrable oralmente
BR0312573A (pt) Derivados de fenil-[4-(3-fenil-1h-pirazol-4-il)-pirimidin-2-il]-amina
ME01239B (me) Čvrsti preparat koji sadrži alogliptin i pioglitazon
BRPI0506970B8 (pt) derivados de alfa-aminoamida úteis no tratamento de distúrbios do trato urinário inferior
RU2011115406A (ru) Новые пиримидиновые производные и их применение в терапии, а также применение пиримидиновых производных в изготовлении лекарственного средства для предупреждения и/или лечения болезни альцгеймера
WO2006078463A3 (en) Method for treating cardiovascular disease
NO20075111L (no) Farmasoytisk sammensetning
AR050717A1 (es) Composiciones farmaceuticas
BRPI0513379A (pt) derivados de sulfonamida
WO2005077103A3 (en) Compositions and methods for modification and prevention of sars coronavirus infectivity
WO2009000552A3 (en) Compositions for the treatment of hyperphenylalaninemia
ATE437679T1 (de) Wässrige antitranspirant formulierung
ECSP045307A (es) Combinacion de compuestos organicos
WO2006123031A3 (fr) Composition pharmaceutique comprenant un onguent oleagineux et de la vitamine d ou l’un de ses derives a l'etat solubilise
WO2006088814A3 (en) Dosage form and method for sustained release of a substituted pyrazine compound
UA90893C2 (ru) Пероральная дозированная форма производных гемцитабина
NO20071798L (no) Dermalt pafore formuleringer for behandling av hudsykdommer i dyr
ATE507827T1 (de) Behandlung pervasiver entwicklungsstörungen
EA200702336A1 (ru) ПРИМЕНЕНИЕ 24-норУДХК
BRPI0511125A (pt) usos de ácido 5,6,7-triidroxieptanóico seus e análogos
WO2005032234A3 (fr) Agent reduisant les consequences nefastes de l'intoxication ethylique aigue
WO2005084695A3 (en) Use of carboxypeptidase g for combating antifolate toxicity

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase